<rst>
<header>
	<relations>
			<rel name="elaboration" type="rst"/>
			<rel name="means" type="rst"/>
			<rel name="circumstance" type="rst"/>
			<rel name="condition" type="rst"/>
			<rel name="concession" type="rst"/>
			<rel name="purpose" type="rst"/>
			<rel name="restatement" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="same_unit" type="multinuc"/>
			<rel name="contrast" type="multinuc"/>
			<rel name="joint" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">2. Conventional Mouse Models for Liver Cancer</segment>
<segment id="2" parent="1002" relname="preparation">A relatively large number of mouse models are presently available for the study of hepatocarcinogenesis .</segment>
<segment id="3" parent="1004" relname="span">The common ones are chemically induced models , genetically engineered mouse</segment>
<segment id="4" parent="3" relname="elaboration">( GEM )</segment>
<segment id="5" parent="1003" relname="same_unit">models , implantation models , and viral models .</segment>
<segment id="6" parent="1006" relname="contrast">Our aim here is not to review all mouse models for liver cancer</segment>
<segment id="7" parent="1009" relname="span">but rather to provide examples of the representative ones , mostly chemically induced or genetically engineered models</segment>
<segment id="8" parent="7" relname="elaboration">( GEMs )</segment>
<segment id="9" parent="1009" relname="elaboration">that have been integrated to genomics of human HCCs</segment>
<segment id="10" parent="1008" relname="elaboration">(</segment>
<segment id="11" parent="1011" relname="preparation">Figure 1</segment>
<segment id="12" parent="1011" relname="joint">) .</segment>
<segment id="13" parent="1011" relname="joint">2.1 .</segment>
<segment id="14" parent="1014" relname="preparation">Chemically Induced Models</segment>
<segment id="15" parent="1014" relname="joint">Chemically induced hepatocarcinogenesis is caused by an irreversible process of structural DNA changes .</segment>
<segment id="16" parent="1018" relname="span">The most widely used chemical</segment>
<segment id="17" parent="16" relname="purpose">to induce liver cancer in mice is diethylnitrosamine</segment>
<segment id="18" parent="1018" relname="restatement">( DEN )</segment>
<segment id="19" parent="1016" relname="same_unit">( Table 1 ) .</segment>
<segment id="20" parent="1020" relname="span">DEN is a DNA alkylating agent</segment>
<segment id="21" parent="1022" relname="condition">and when injected into juvenile mice ,</segment>
<segment id="22" parent="1022" relname="span">it forms mutagenic DNA adducts ,</segment>
<segment id="23" parent="22" relname="elaboration">which are generated rapidly in centrilobular hepatocytes .</segment>
<segment id="24" parent="1014" relname="joint">DEN is metabolic activated in hepatocytes by enzymes of the cytochrome P450 family</segment>
<segment id="25" parent="1025" relname="same_unit">and acts as a complete carcinogen</segment>
<segment id="26" parent="1027" relname="condition">if injected into young mice younger than two weeks old</segment>
<segment id="27" parent="1028" relname="span">with actively proliferating hepatocytes</segment>
<segment id="28" parent="27" relname="elaboration">resulting in dysplastic nodules ,</segment>
<segment id="29" parent="1028" relname="elaboration">which progress to carcinoma .</segment>
<segment id="30" parent="1033" relname="condition">If given to an older mouse ,</segment>
<segment id="31" parent="1033" relname="span">additional stimulation is required for instance , phenobarbital</segment>
<segment id="32" parent="31" relname="elaboration">( PB ) ,</segment>
<segment id="33" parent="1031" relname="span">carbon tetrachloride , or high-fat diet feeding .</segment>
<segment id="34" parent="1036" relname="span">In addition , oxidative stress</segment>
<segment id="35" parent="1037" relname="span">induced by reactive oxygen species</segment>
<segment id="36" parent="35" relname="restatement">( ROS )</segment>
<segment id="37" parent="1038" relname="span">during DEN metabolization is known to contribute to hepatocarcinogenesis</segment>
<segment id="38" parent="37" relname="circumstance">as they cause DNA , protein , and lipid damage .</segment>
<segment id="39" parent="1040" relname="span">The mutational landscape of a DEN-induced tumor was described in a recent study</segment>
<segment id="40" parent="39" relname="means">using the whole exome sequencing technique .</segment>
<segment id="41" parent="1041" relname="joint">A high burden of somatic mutation was observed</segment>
<segment id="42" parent="1042" relname="span">and almost all of the DNA changes in the DEN-induced tumors were single-base substitutions .</segment>
<segment id="43" parent="1044" relname="span">Four recurrently mutated genes</segment>
<segment id="44" parent="43" relname="elaboration">that are putative oncogenic drivers of DEN-induced tumors</segment>
<segment id="45" parent="1043" relname="same_unit">were Hras , Braf , Egfr , and Apc .</segment>
<segment id="46" parent="1046" relname="span">The incidence of Hras was the highest</segment>
<segment id="47" parent="1047" relname="span">reaching approximately 80 %</segment>
<segment id="48" parent="47" relname="elaboration">suggesting selective advantage during hepatocarcinogenesis .</segment>
<segment id="49" parent="1014" relname="joint">Hras , Braf , and Egfr mutations were present in every DEN-induced HCC with mutual exclusivity</segment>
<segment id="50" parent="1014" relname="joint">and may replace each other in terms of oncogenic drivers .</segment>
<segment id="51" parent="1052" relname="span">Activation of the Ras/Raf/MEK/ERK signal transduction pathway was the hallmark feature in the DEN-induced mouse model</segment>
<segment id="52" parent="51" relname="elaboration">which is rare in human HCC .</segment>
<segment id="53" parent="1052" relname="elaboration">Of note , TP53 and CTNNB1 , the most frequently altered genes in human were never found in DEN-induced tumors .</segment>
<segment id="54" parent="55" relname="concession">Although ctnnb1 mutation is not observed in DEN-induced model ,</segment>
<segment id="55" parent="1054" relname="span">its mutation is known to be observed in a two-stage model , the DEN-initiated and PB-promoted protocol .</segment>
<segment id="56" parent="1053" relname="joint">In addition , loss of Apc function , mutation and aberrant nuclear expression of β-catenin may disrupt the canonical Wnt/β-catenin pathway .</segment>
<segment id="57" parent="1060" relname="span">The Stelic Animal Model</segment>
<segment id="58" parent="57" relname="elaboration">( STAM )</segment>
<segment id="59" parent="1059" relname="same_unit">demonstrates non-alcoholic steatohepatitis</segment>
<segment id="60" parent="1059" relname="elaboration">( NASH )</segment>
<segment id="61" parent="1061" relname="span">progression</segment>
<segment id="62" parent="61" relname="elaboration">resembling the disease in humans .</segment>
<segment id="63" parent="1053" relname="joint">Since NASH is evolving as a major cause of non-viral HCC</segment>
<segment id="64" parent="1064" relname="span">and may account for a large proportion of HCC in developed countries in recent years ,</segment>
<segment id="65" parent="1065" relname="span">HCC</segment>
<segment id="66" parent="65" relname="elaboration">arising from NASH is important .</segment>
<segment id="67" parent="1068" relname="span">The STAM model is created by combination of chemical</segment>
<segment id="68" parent="67" relname="elaboration">( a single subcutaneous injection of 200 μg of streptozotocin at two days after birth )</segment>
<segment id="69" parent="1070" relname="span">and dietary intervention</segment>
<segment id="70" parent="69" relname="elaboration">( high-fat diet ad libitum four weeks after injection )</segment>
<segment id="71" parent="1069" relname="same_unit">in C57BL/6 mice .</segment>
<segment id="72" parent="1072" relname="span">STAM mice manifest NASH at eight weeks ,</segment>
<segment id="73" parent="72" relname="elaboration">which progresses to fibrosis at 12 weeks ,</segment>
<segment id="74" parent="1053" relname="joint">and eventually develops into HCC at a rate of nearly 100 % in males .</segment>
<segment id="75" parent="1076" relname="span">The STAM model had pathway mutation rates comparable to those in humans for most pathways with more alterations in receptor tyrosine kinase</segment>
<segment id="76" parent="75" relname="elaboration">( RTK )</segment>
<segment id="77" parent="1075" relname="same_unit">signaling and chromatin-modification genes .</segment>
<segment id="78" parent="79" relname="concession">This model also showed low mutation rate of TP53</segment>
<segment id="79" parent="1078" relname="span">but the cell-cycle pathway alteration rate was similar to human tumors .</segment>
<segment id="80" parent="1080" relname="span">The limitation of this model is that the model does not show obesity or insulin resistance ,</segment>
<segment id="81" parent="80" relname="elaboration">which is the common characteristics of patients with NASH .</segment>
<segment id="82" parent="1079" relname="joint">2.2 .</segment>
<segment id="83" parent="1079" relname="joint">Genetically Engineered Mouse Models</segment>
<segment id="84" parent="1085" relname="span">Genetically engineered mouse</segment>
<segment id="85" parent="84" relname="restatement">( GEM )</segment>
<segment id="86" parent="1086" relname="span">models recapitulate the multistep process of hepatocarcinogenesis with multiple genetic and epigenetic changes</segment>
<segment id="87" parent="86" relname="elaboration">occurring along each stage of progression toward cancer formation .</segment>
<segment id="88" parent="1079" relname="joint">They are highly useful for assessing the impacts of a driver oncogene alone or in combination with other driver oncogenes or tumor suppressors .</segment>
<segment id="89" parent="1090" relname="span">Recently , the Cancer Genome Atlas</segment>
<segment id="90" parent="89" relname="elaboration">( TCGA )</segment>
<segment id="91" parent="1091" relname="span">characterized the genomic landscape of HCC</segment>
<segment id="92" parent="1092" relname="span">using large-scale multi-platform analysis of HCC ,</segment>
<segment id="93" parent="92" relname="elaboration">including evaluation of somatic mutations and copy number alterations .</segment>
<segment id="94" parent="1093" relname="joint">Commonly altered pathways such as cell cycle pathway , RTK/RAS/PI3K , and WNT pathways were also identified</segment>
<segment id="95" parent="1095" relname="span">and therefore , data</segment>
<segment id="96" parent="95" relname="elaboration">generated from GEMs would be useful</segment>
<segment id="97" parent="1096" relname="joint">in developing novel therapies</segment>
<segment id="98" parent="1097" relname="span">and be tested in the preclinical setting</segment>
<segment id="99" parent="98" relname="condition">if they recapitulate human HCCs .</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1000" relname="span"/>
<group id="1002" type="multinuc" parent="1001" relname="span"/>
<group id="1003" type="multinuc" parent="1002" relname="joint"/>
<group id="1004" type="span" parent="1003" relname="same_unit"/>
<group id="1006" type="multinuc" parent="1002" relname="joint"/>
<group id="1007" type="span" parent="1006" relname="contrast"/>
<group id="1008" type="span" parent="1007" relname="span"/>
<group id="1009" type="span" parent="1008" relname="span"/>
<group id="1010" type="span" parent="1002" relname="joint"/>
<group id="1011" type="multinuc" parent="1010" relname="span"/>
<group id="1013" type="span" parent="1011" relname="joint"/>
<group id="1014" type="multinuc" parent="1013" relname="span"/>
<group id="1016" type="multinuc" parent="1014" relname="joint"/>
<group id="1017" type="span" parent="1016" relname="same_unit"/>
<group id="1018" type="span" parent="1017" relname="span"/>
<group id="1020" type="span" parent="1014" relname="joint"/>
<group id="1021" type="span" parent="20" relname="elaboration"/>
<group id="1022" type="span" parent="1021" relname="span"/>
<group id="1025" type="multinuc" parent="1014" relname="joint"/>
<group id="1026" type="span" parent="1025" relname="same_unit"/>
<group id="1027" type="span" parent="1026" relname="span"/>
<group id="1028" type="span" parent="1027" relname="span"/>
<group id="1031" type="span" parent="1014" relname="joint"/>
<group id="1032" type="span" parent="33" relname="condition"/>
<group id="1033" type="span" parent="1032" relname="span"/>
<group id="1035" type="multinuc" parent="1014" relname="joint"/>
<group id="1036" type="span" parent="1035" relname="same_unit"/>
<group id="1037" type="span" parent="34" relname="elaboration"/>
<group id="1038" type="span" parent="1035" relname="same_unit"/>
<group id="1039" type="span" parent="1014" relname="joint"/>
<group id="1040" type="span" parent="1039" relname="span"/>
<group id="1041" type="multinuc" parent="1040" relname="elaboration"/>
<group id="1042" type="span" parent="1041" relname="joint"/>
<group id="1043" type="multinuc" parent="42" relname="elaboration"/>
<group id="1044" type="span" parent="1043" relname="same_unit"/>
<group id="1046" type="span" parent="1014" relname="joint"/>
<group id="1047" type="span" parent="46" relname="elaboration"/>
<group id="1050" type="span" parent="1014" relname="joint"/>
<group id="1051" type="span" parent="1053" relname="preparation"/>
<group id="1052" type="span" parent="1051" relname="span"/>
<group id="1053" type="multinuc" parent="1050" relname="span"/>
<group id="1054" type="span" parent="1053" relname="joint"/>
<group id="1057" type="multinuc" parent="1053" relname="joint"/>
<group id="1058" type="span" parent="1057" relname="same_unit"/>
<group id="1059" type="multinuc" parent="1058" relname="span"/>
<group id="1060" type="span" parent="1059" relname="same_unit"/>
<group id="1061" type="span" parent="1057" relname="same_unit"/>
<group id="1064" type="span" parent="1053" relname="joint"/>
<group id="1065" type="span" parent="64" relname="elaboration"/>
<group id="1067" type="multinuc" parent="1053" relname="joint"/>
<group id="1068" type="span" parent="1067" relname="same_unit"/>
<group id="1069" type="multinuc" parent="1067" relname="same_unit"/>
<group id="1070" type="span" parent="1069" relname="same_unit"/>
<group id="1072" type="span" parent="1053" relname="joint"/>
<group id="1075" type="multinuc" parent="1053" relname="joint"/>
<group id="1076" type="span" parent="1075" relname="same_unit"/>
<group id="1077" type="span" parent="1053" relname="joint"/>
<group id="1078" type="span" parent="1079" relname="preparation"/>
<group id="1079" type="multinuc" parent="1077" relname="span"/>
<group id="1080" type="span" parent="1079" relname="joint"/>
<group id="1084" type="multinuc" parent="1079" relname="joint"/>
<group id="1085" type="span" parent="1084" relname="same_unit"/>
<group id="1086" type="span" parent="1084" relname="same_unit"/>
<group id="1088" type="span" parent="1079" relname="joint"/>
<group id="1089" type="multinuc" parent="1088" relname="span"/>
<group id="1090" type="span" parent="1089" relname="same_unit"/>
<group id="1091" type="span" parent="1089" relname="same_unit"/>
<group id="1092" type="span" parent="91" relname="means"/>
<group id="1093" type="multinuc" parent="1089" relname="elaboration"/>
<group id="1094" type="multinuc" parent="1093" relname="joint"/>
<group id="1095" type="span" parent="1094" relname="same_unit"/>
<group id="1096" type="multinuc" parent="1094" relname="same_unit"/>
<group id="1097" type="span" parent="1096" relname="joint"/>
	</body>
</rst>
